mirror of
https://github.com/msberends/AMR.git
synced 2025-07-17 13:53:17 +02:00
(v1.7.1.9040) Support for Danish
This commit is contained in:
@ -44,7 +44,7 @@
|
||||
</button>
|
||||
<span class="navbar-brand">
|
||||
<a class="navbar-link" href="../index.html">AMR (for R)</a>
|
||||
<span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Latest development version">1.7.1.9030</span>
|
||||
<span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Latest development version">1.7.1.9040</span>
|
||||
</span>
|
||||
</div>
|
||||
|
||||
@ -185,7 +185,7 @@
|
||||
|
||||
|
||||
|
||||
</header><script src="MDR_files/header-attrs-2.9/header-attrs.js"></script><div class="row">
|
||||
</header><script src="MDR_files/header-attrs-2.11/header-attrs.js"></script><div class="row">
|
||||
<div class="col-md-9 contents">
|
||||
<div class="page-header toc-ignore">
|
||||
<h1 data-toc-skip>How to determine multi-drug resistance (MDR)</h1>
|
||||
@ -357,19 +357,19 @@ Unique: 2</p>
|
||||
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
|
||||
<code class="sourceCode R"><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">my_TB_data</span><span class="op">)</span>
|
||||
<span class="co"># rifampicin isoniazid gatifloxacin ethambutol pyrazinamide moxifloxacin</span>
|
||||
<span class="co"># 1 S I I R I I</span>
|
||||
<span class="co"># 2 S S I I R R</span>
|
||||
<span class="co"># 3 I S S I I R</span>
|
||||
<span class="co"># 4 S R S R S R</span>
|
||||
<span class="co"># 5 R S R S R R</span>
|
||||
<span class="co"># 6 I S S R I S</span>
|
||||
<span class="co"># 1 S S R R I I</span>
|
||||
<span class="co"># 2 S R R S I S</span>
|
||||
<span class="co"># 3 S I I S R I</span>
|
||||
<span class="co"># 4 I I R I S I</span>
|
||||
<span class="co"># 5 R I R R S S</span>
|
||||
<span class="co"># 6 I R S I I R</span>
|
||||
<span class="co"># kanamycin</span>
|
||||
<span class="co"># 1 I</span>
|
||||
<span class="co"># 2 R</span>
|
||||
<span class="co"># 3 I</span>
|
||||
<span class="co"># 4 R</span>
|
||||
<span class="co"># 2 S</span>
|
||||
<span class="co"># 3 S</span>
|
||||
<span class="co"># 4 I</span>
|
||||
<span class="co"># 5 R</span>
|
||||
<span class="co"># 6 I</span></code></pre></div>
|
||||
<span class="co"># 6 S</span></code></pre></div>
|
||||
<p>We can now add the interpretation of MDR-TB to our data set. You can use:</p>
|
||||
<div class="sourceCode" id="cb9"><pre class="downlit sourceCode r">
|
||||
<code class="sourceCode R"><span class="fu"><a href="../reference/mdro.html">mdro</a></span><span class="op">(</span><span class="va">my_TB_data</span>, guideline <span class="op">=</span> <span class="st">"TB"</span><span class="op">)</span></code></pre></div>
|
||||
@ -412,40 +412,40 @@ Unique: 5</p>
|
||||
<tr class="odd">
|
||||
<td align="left">1</td>
|
||||
<td align="left">Mono-resistant</td>
|
||||
<td align="right">3144</td>
|
||||
<td align="right">62.88%</td>
|
||||
<td align="right">3144</td>
|
||||
<td align="right">62.88%</td>
|
||||
<td align="right">3194</td>
|
||||
<td align="right">63.88%</td>
|
||||
<td align="right">3194</td>
|
||||
<td align="right">63.88%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">2</td>
|
||||
<td align="left">Negative</td>
|
||||
<td align="right">1027</td>
|
||||
<td align="right">20.54%</td>
|
||||
<td align="right">4171</td>
|
||||
<td align="right">83.42%</td>
|
||||
<td align="right">964</td>
|
||||
<td align="right">19.28%</td>
|
||||
<td align="right">4158</td>
|
||||
<td align="right">83.16%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">3</td>
|
||||
<td align="left">Multi-drug-resistant</td>
|
||||
<td align="right">464</td>
|
||||
<td align="right">9.28%</td>
|
||||
<td align="right">4635</td>
|
||||
<td align="right">92.70%</td>
|
||||
<td align="right">451</td>
|
||||
<td align="right">9.02%</td>
|
||||
<td align="right">4609</td>
|
||||
<td align="right">92.18%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">4</td>
|
||||
<td align="left">Poly-resistant</td>
|
||||
<td align="right">257</td>
|
||||
<td align="right">5.14%</td>
|
||||
<td align="right">4892</td>
|
||||
<td align="right">97.84%</td>
|
||||
<td align="right">253</td>
|
||||
<td align="right">5.06%</td>
|
||||
<td align="right">4862</td>
|
||||
<td align="right">97.24%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">5</td>
|
||||
<td align="left">Extensively drug-resistant</td>
|
||||
<td align="right">108</td>
|
||||
<td align="right">2.16%</td>
|
||||
<td align="right">138</td>
|
||||
<td align="right">2.76%</td>
|
||||
<td align="right">5000</td>
|
||||
<td align="right">100.00%</td>
|
||||
</tr>
|
||||
@ -464,7 +464,7 @@ Unique: 5</p>
|
||||
|
||||
<footer><div class="copyright">
|
||||
<p></p>
|
||||
<p>Developed by <a href="https://www.rug.nl/staff/m.s.berends/" class="external-link external-link">Matthijs S. Berends</a>, <a href="https://www.rug.nl/staff/c.f.luz/" class="external-link external-link">Christian F. Luz</a>, <a href="https://www.rug.nl/staff/a.w.friedrich/" class="external-link external-link">Alexander W. Friedrich</a>, <a href="https://www.rug.nl/staff/b.sinha/" class="external-link external-link">Bhanu N. M. Sinha</a>, <a href="https://www.rug.nl/staff/c.j.albers/" class="external-link external-link">Casper J. Albers</a>, <a href="https://www.rug.nl/staff/c.glasner/" class="external-link external-link">Corinna Glasner</a>.</p>
|
||||
<p>Developed by <a href="https://www.rug.nl/staff/m.s.berends/" class="external-link external-link">Matthijs S. Berends</a>, Christian F. Luz.</p>
|
||||
</div>
|
||||
|
||||
<div class="pkgdown">
|
||||
|
Reference in New Issue
Block a user